Abstract
Objective: To review the hemorrhagic disease of the newborn, the different prophylaxis schemes with vitamin K that exist, and their impact on the morbidity and mortality of newborns due to parental refusal. Bibliographic review: Newborns are at greater risk of developing bleeding due to some peculiarities, such as poor placental transfer to the fetus during prenatal care, reduced vitamin K-dependent clotting factors, and lower storage capacity. Vitamin K deficiency bleeding can be categorized based on time of onset (early, classic, and late) and etiology (idiopathic or secondary). Given this, since 1961, the American Academy of Pediatrics has recommended the administration of a single intramuscular (IM) injection at a dose of 0.5 to 1.0 mg of vitamin K after birth to all newborns. Although this prophylaxis is universally recommended, it has been observed that prevention using the oral route has become more widespread due to increasing parental refusal in recent decades. Final considerations: It was verified that the traditional intramuscular method still has lower rates of late bleeding and, consequently, lower morbidity and mortality compared to oral therapy.
References
ARAKI S e SHIRAHATA A. Vitamin K Deficiency Bleeding in Infancy. Nutrients, 2020; 12(3): 780.
BURKE M, et al. Perinatal influences on the uptake of newborn Vitamin K prophylaxis - a retrospective cohort study. Australian and New Zealand Journal of Public Health, 2015; 39(6): 573–576.
CLARKE P, et al. Total and Differential Phylloquinone (Vitamin K1) Intakes of Preterm Infants from All Sources during the Neonatal Period. Nutrients, 2015; 7(10): 8308–8320.
COFFEY PS e GERTH-GUYETTE, E. Current perspectives and practices of newborn vitamin K administration in low and middle income countries. Research and Reports in Neonatol, 2018; 8: 45–51.
DAM H. The antihaemorrhagic vitamin of the chick. Biochem J, 1935; 29(6):1273-1285.
EKELUND H, et al. Administration of vitamin K to newborn infants and childhood cancer. BMJ;1993; 307 (6896): 89–91.
GOLDING J, et al. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. British Medical Journal, 1992; 305(6849): 341-346.
HAND I, et al. Vitamin K and the Newborn Infant. Pediatrics, 2022; 149(3): e2021056036.
HASCOËT JM, et al. Vitamine K chez le nouveau-né: mise à jour des recommandations. Archives de Pédiatrie, 2017; 24(9): 902–905.
HOLLEY SL, et al. Educating Parents on Vitamin K Prophylaxis for Newborns. Nursing for Women’s Health, 2020; 24(4): 283–293.
JULLIEN S. Vitamin K prophylaxis in newborns. BMC Pediatrics, 2021; 21(S1): 350.
KLEBANOFF MA, et al. The risk of childhood cancer after neonatal exposure to vitamin K. New England Journal of Medicine, 1993; 329(13): 905-908.
LEMBO C, et al. The challenge to define the optimal prophylactic regimen for vitamin K deficiency bleeding in infants. Acta Paediatrica, 2021; 110(4): 1113–1118.
LÖWENSTEYN YN, et al. Increasing the dose of oral vitamin K prophylaxis and its effect on bleeding risk. European Journal of Pediatrics, 2019; 178(7): 1033–1042.
LOYAL J e SHAPIRO ED. Refusal of Intramuscular Vitamin K by Parents of Newborns: A Review. Hospital Pediatrics, 2020; 10(3): 286–294.
MAJID A, et al. Newborn Vitamin K Prophylaxis: A Historical Perspective to Understand Modern Barriers to Uptake. Hospital Pediatrics, 2019; 9(1): 55–60.
MIHATSCH WA, et al. Prevention of Vitamin K Deficiency Bleeding in Newborn Infants: A Position Paper by the ESPGHAN Committee on Nutrition. Journal of Pediatric Gastroenterology & Nutrition, 2016; 63(1): 123–129.
NG E e LOEWY AD. Guidelines for vitamin K prophylaxis in newborns. Paediatrics & Child Health, 2018; 23(6): 394–397.
PHILLIPPI JC, et al. Prevention of Vitamin K Deficiency Bleeding. Journal of Midwifery & Women’s Health, 2016; 61(5): 632–636.
PUCKETT RM e OFFRINGA M. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database of Systematic Reviews, 2000.
SANKAR MJ, et al. Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systematic review. Journal of Perinatology, 2016; 36(S1): S29–S35.
WADDELL WW, et al. Possible effects of vitamin K on prothrombin and clotting time in newly-born infants. J Path Bact, 1937; (44):633–635.
WITT M, et al. Prophylactic Dosing of Vitamin K to Prevent Bleeding. Pediatrics, 2016; 137(5): e20154222.
WORLD HEALTH ORGANIZATION. Educational modules on clinical use of blood. Geneva: World Health Organization, 2021.
ZURYNSKI Y, et al. Vitamin K deficiency bleeding in Australian infants 1993–2017: an Australian Paediatric Surveillance Unit study. Archives of Disease in Childhood, 2020; 105(5): 433–438.
